John Potts - NantKwest Independent Director
Director
Dr. John T. Potts, Jr. M.D. serves as an Independent Director of the Company. Dr. Potts currently serves as the Distinguished Jackson Professor of Clinical Medicine at the Massachusetts General Hospital, or MGH, and Harvard Medical School and on the MPM BioVentures Medical Scientific Advisory Board. Dr. Potts was with MGH since 1968. Dr. Potts served as a director of Cell Genesys, Inc., a therapeutic products company from May 1997 to October 2009 when Cell Genesys merged with BioSante Pharmaceuticals, Inc., a pharmaceutical products company, or BioSante. Dr. Potts served as a director of BioSante from October 2009 to July 2013. After medical training at the University of Pennsylvania, he completed his internship and residency at the MGH from 1957 to 1959, and then went to the National Institutes of Health, or NIH, to work with Nobel Laureate Christian Anfinsen in protein chemistry. Dr. Potts remained at the NIH from 1959 to 1968, when he returned to the MGH as Chief of the Endocrine Unit. He served as Chairman of the Department of Medicine and PhysicianinChief from 1981 to 1996, and as Director of Research from 1995 to 2004. Dr. Potts has authored or coauthored over 500 scientific publications, is the recipient of the Fred Conrad Koch Award of the Endocrine Society, and is a member of the National Academy of Sciences, the Institute of Medicine, and the American Academy of Arts and Sciences. He holds active and honorary memberships in numerous scientific and professional organizations. since 2014.
| Age | 84 |
| Tenure | 10 years |
| Phone | 858 633-0300 |
| Web | www.nantkwest.com |
NantKwest Management Efficiency
The company has Return on Asset (ROA) of (38.83) % which means that for every 100 dollars spent on asset, it generated a loss of $38.83. This is way below average. Likewise, it shows a return on total equity (ROE) of (77.61) %, which implies that it produced no returns to current stockholders. NantKwest's management efficiency ratios could be used to measure how well NantKwest manages its routine affairs as well as how well it operates its assets and liabilities.The company reports 15.31 M of total liabilities with total debt to equity ratio (D/E) of 0.13, which may suggest the company is not taking enough advantage from financial leverage. NantKwest has a current ratio of 3.0, indicating that it is in good position to pay out its debt commitments in time. Debt can assist NantKwest until it has trouble settling it off, either with new capital or with free cash flow. So, NantKwest's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like NantKwest sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for NantKwest to invest in growth at high rates of return. When we think about NantKwest's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Paula Reynolds | Delta Air Lines | 58 | |
| Katherine Savitt | Alaska Air Group | 51 | |
| CHRISTOPHER HAZLETON | Delta Air Lines | 52 | |
| James Thompson | Alaska Air Group | 70 | |
| Shirley Franklin | Delta Air Lines | 69 | |
| John Klockau | ICC Holdings | 66 | |
| Anastassis David | Aegean Airlines SA | 46 | |
| Rickey Plunkett | ICC Holdings | 62 | |
| Ash Carter | Delta Air Lines | N/A | |
| Katherine SavittLennon | Alaska Air Group | 51 | |
| Vittorio Pisante | Aegean Airlines SA | 47 | |
| Kathy Waller | Delta Air Lines | 61 | |
| Jessie Knight | Alaska Air Group | 70 | |
| Dennis Madsen | Alaska Air Group | 67 | |
| Jeanne Jackson | Delta Air Lines | 68 | |
| Peter Boneparth | JetBlue Airways Corp | 57 | |
| Ben Baldanza | JetBlue Airways Corp | 53 | |
| Dhiren Fonseca | Alaska Air Group | 56 | |
| Michael Huerta | Delta Air Lines | 63 | |
| Christos Ioannou | Aegean Airlines SA | 43 | |
| Kathleen Springer | ICC Holdings | 56 | |
Management Performance
| Return On Equity | -77.61 | |||
| Return On Asset | -38.83 |
NantKwest Leadership Team
Elected by the shareholders, the NantKwest's board of directors comprises two types of representatives: NantKwest inside directors who are chosen from within the company, and outside directors, selected externally and held independent of NantKwest. The board's role is to monitor NantKwest's management team and ensure that shareholders' interests are well served. NantKwest's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, NantKwest's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Cheryl Cohen, Director | ||
| Richard Kusserow, Independent Director | ||
| Angela Wilson, CFO | ||
| Sonja Nelson, Chief Accounting Officer | ||
| Barry Simon, President CEO, Board Member | ||
| Michael Blaszyk, Independent Director | ||
| Frederick Driscoll, Independent Director | ||
| John Thomas, Independent Director | ||
| Robert Rosen, Director | ||
| Richard Tajak, Interim CFO | ||
| Patrick SoonShiong, Chairman of the Board, CEO | ||
| Henry Ji, Director | ||
| John Potts, Independent Director | ||
| Steven Gorlin, Vice Chairman of the Board |
NantKwest Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is NantKwest a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -77.61 | |||
| Return On Asset | -38.83 | |||
| Current Valuation | 2.76 B | |||
| Shares Outstanding | 108.88 M | |||
| Shares Owned By Insiders | 67.98 % | |||
| Shares Owned By Institutions | 9.78 % | |||
| Number Of Shares Shorted | 5.43 M | |||
| Price To Earning | (3.44) X | |||
| Price To Book | 19.58 X | |||
| Revenue | 111 K |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards NantKwest in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, NantKwest's short interest history, or implied volatility extrapolated from NantKwest options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in NantKwest Stock
If you are still planning to invest in NantKwest check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NantKwest's history and understand the potential risks before investing.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |